gvtcx

supplier · GB-PPONPDJG-8184-TCQQ

Amgen Ltd

CB40WD combined from 3 published records

Amgen Ltd has won 72 UK public sector awards from 11 buyers since 2017. The typical award is worth £261,895,933.

as a supplier

72 recorded awards from 11 buyers , between 10 Aug 2017 and 3 Jun 2026.

awards won
72
exclusive
3%
2 sole-winner awards
median award
£261.9m
largest
£986.3m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

common questions about Amgen Ltd

How many public sector contracts has Amgen Ltd won?

Amgen Ltd has won 72 UK public sector contracts from 11 public bodies since 2017.

Which public bodies buy from Amgen Ltd?

Amgen Ltd has won the most contracts from NHS England, The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") and NHS England.

How large are Amgen Ltd's contracts?

The median published value of a contract won by Amgen Ltd is £261,895,933. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.

Which Amgen Ltd contracts are expiring soon?

4 contracts involving Amgen Ltd have end dates in the next 12 months, the earliest on 31 Aug 2027.

contracts expiring in the next 12 months

Contract end dates as published on the original notice. An end date is not a commitment to re-tender — a contract may be extended, varied or allowed to lapse — but it is the earliest public signal that work may come back to market.

contracts won

contractbuyervalueawarded
Transitional Drugs 7 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £16,804,001 3 Jun 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 shared NHS England £813,863,584 31 May 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 shared NHS England £18,903,212 31 May 2026
Transitional Drugs 6 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £1,637,728 29 Jan 2026
NHS National Framework for Denosumab Injection commencing 1st January 2026 shared NHS England £15,059,000 29 Sept 2025
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 shared NHS England £986,282,758 30 Jun 2025
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab shared NHS England £230,000,000 12 Aug 2024
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 shared NHS England £1,009,500,000 4 Apr 2024
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 shared NHS England £688,010,000 26 Jan 2024
NHS South of England Branded Medicines - Tranche A - September 2023 shared NHS ENGLAND £249,832,000 17 Jul 2023
NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023 shared NHS England £264,003,228 3 Mar 2023
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023
NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual shared NHS England £153,778,681 14 Jul 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual shared NHS England £216,078,796 7 Feb 2022
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England £558,521,926 18 Aug 2021
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche shared NHS England £1 11 Feb 2021
NHS Framework for the Midlands and East, Branded Medicines - Tranche B shared NHS England £228,156,862 25 Jan 2021
NHS Framework Colorectal Cancer Drugs (See description below) shared NHS England £75,000,000 13 Nov 2020
NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared NHS England £191,062,951 16 Jun 2020
NHS National Framework Agreement for Adalimumab Injection shared NHS England £445,000,000 6 Mar 2020
NHS Framework Agreement - North of England - Tranche B shared NHS England £205,535,556 13 Feb 2020
NHS Midlands and East Branded Medicines - Tranche A shared NHS England £418,787,000 15 Jan 2020

every contract won by Amgen Ltd →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Amgen Ltd · CB4 0WD 52
Amgen Ltd. GB-COH 02354269 · 12
AMGEN LIMITED GB-PPON PDJG-8184-TCQQ CB4 0WA 8

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works

where these figures come from

Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 11 Sept 2026 and is refreshed from the publishers' own APIs through the working day.

Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations. The 3 published records behind this page are listed above exactly as filed, so any merge can be checked.

Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works

Contains public sector information licensed under the Open Government Licence v3.0.